The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Randomized trial of vitamin D3 to prevent worsening of musculoskeletal symptoms and fatigue in women with breast cancer starting adjuvant letrozole: The VITAL trial.
Qamar J. Khan
Honoraria - Abraxis BioScience; Genentech
Research Funding - Abraxis BioScience; Novartis; Roche/Genentech
Bruce F. Kimler
No relevant relationships to disclose
Pavan S. Reddy
No relevant relationships to disclose
Priyanka Sharma
No relevant relationships to disclose
Jennifer R. Klemp
No relevant relationships to disclose
Carol J. Fabian
No relevant relationships to disclose